45
Participants
Start Date
October 31, 2011
Primary Completion Date
March 31, 2013
Study Completion Date
March 31, 2013
Tapentadol (OS) Oral Solution
Tapentadol OS Bodyweight \<20 kg: Type=4 unit=mg/mL form=oral solution route=oral use or Tapentadol OS Bodyweight \>=20 kg: Type=20 unit=mg/mL form=oral solution route=oral use. Single oral dose administered once.
Little Rock
Washington D.C.
Meridian
Ann Arbor
The Bronx
Charlotte
Durham
Toledo
Pittsburgh
Salt Lake City
Hamilton
Ottawa
Sherbrooke
F-75 730 Paris Cedex 15
Rennes
Madrid
Valladolid
Collaborators (1)
Grünenthal GmbH
INDUSTRY
Janssen Research & Development, LLC
INDUSTRY